Striatal Medium Spiny Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Striatal Medium Spiny Neurons (MSNs) are the principal neurons of the striatum, comprising approximately 95% of the striatal neuronal population. These GABAergic projection neurons are the primary efferent output of the basal ganglia and play critical roles in motor control, habit formation, and reward learning.
| Property | Value |
|---|---|
| Category | Neurons |
| Brain Region | Striatum (Caudate Nucleus, Putamen) |
| Neurotransmitter | GABA (inhibitory) |
| Primary Input | Cortex, Thalamus, Substantia Nigra (dopamine) |
| Primary Output | Globus Pallidus (external and internal), Substantia Nigra pars reticulata |
Medium spiny neurons are characterized by their medium-sized cell bodies (10-20 μm diameter), dense dendritic spines (approximately 10,000 spines per neuron), and extensive axonal arborization. The dense spine coverage provides the anatomical substrate for corticostriatal synaptic integration, with each MSN receiving approximately 10,000-30,000 synaptic inputs.
The dendritic tree is highly branched and spans 200-400 μm, allowing for extensive integration of excitatory glutamatergic inputs from the cortex and thalamus. The axons give rise to extensive local collaterals that form synaptic connections with other MSNs and interneurons.
Direct pathway MSNs (D1-MSNs): DRD1, PDYN, TAC1, GNAO1
Indirect pathway MSNs (D2-MSNs): DRD2, PENK, GNAI3, RGS9
The striatum contains two anatomically and functionally distinct populations of MSNs:
Direct Pathway (D1-MSNs):
Indirect Pathway (D2-MSNs):
MSNs integrate information from multiple brain regions:
They encode:
MSNs are selectively vulnerable in Huntington's disease, particularly the indirect pathway (D2-MSNs) which degenerate first. This selective vulnerability leads to:
The degeneration pattern follows a characteristic gradient, with the dorsal striatum affected before ventral regions, and the indirect pathway showing greater vulnerability than the direct pathway.
In Parkinson's disease, dopaminergic degeneration in the SNc leads to:
DBS of the STN and GPi helps normalize this circuitry.
Single-cell RNA sequencing has revealed distinct molecular signatures for D1-MSNs and D2-MSNs:
D1-MSNs (Direct Pathway):
D2-MSNs (Indirect Pathway):
The study of Striatal Medium Spiny Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci. 2011;34:441-466. PMID:21469956
Kreitzer AC, Malenka RC. Striatal plasticity and basal ganglia circuit function. Nature. 2008;455(7213):606-612. PMID:18683610
Plotkin JL, Surmeier DJ. Corticostriatal circuit plasticity in Parkinson's disease: from compensatory bursts to pathological oscillations. Mov Disord. 2015;30(5):603-611. PMID:25942039
Raymond LA, André VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS. Pathophysiology of Huntington's disease: time-dependent alterations in synaptic physiology and spiking properties. J Neurosci. 2011;31(32):11710-11721. PMID:21832234
Hersch SM, Ferrante RJ. Neuropathology and biochemistry of Huntington's disease. Front Biosci. 2007;12:3912-3925. PMID:17485379
Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci. 2014;17(8):1022-1030. PMID:25065439
Nelson AB, Kreitzer AC. Reassessing models of basal ganglia function and dysfunction. Annu Rev Neurosci. 2014;37:117-135. PMID:25032493
Yager LM, Garcia AF, Wunsch AM, Ferguson SM. The ins and outs of the striatum: role in normal plasticity and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2015;59:59-72. PMID:25683547